Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients

Figure 3

The ability of ERGRS to distinguish survival probability under different clinical characteristics. (a) In the TCGA cohort, Kaplan-Meier curves of different risk groups with different clinical characteristics, including age, tumor stage, tumor grade, BRCA1 type, and treatment type. (b) Kaplan-Meier curves of different risk groups with different characteristics of age, tumor stage, and tumor grade in the GEO cohort.

(a)

(b)